Skip to main content

Table 2 Characteristics of patients who underwent secondary metastasectomy

From: Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

 

Metastatic sites

Response

TTP (months)

Relapse

Patient 1

Liver

CR

12

No

Patient 2

Liver

PR

13

Yes (Liver)

Patient 3

Lung

PR

4

No

Patient 4

Liver

PR

9

No

Patient 5

Liver

CR

11

Yes (Lung)

Patient 6

Lung

PR

18

No

Patient 7

Liver

PR

7

No

Patient 8

Liver

PR

14

No